| 1 | [SID104234238] | Active | IC50 | 0.01 | Inhibitory activity against production of nitric oxide induced by interferon-gamma in mouse macrophages [AID132692, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibitory activity against production of nitric oxide induced by interferon-gamma in mouse macrophages | | AID | 132692 | | BioAssay type | Literature | | Target | | | PubMed | 10617085 | | Data Table |  |
|
| 2 | [SID104234238] | Active | IC50 | 0.01 | 50 percent inhibitory concentration of compound to inhibit nitric oxide production induced by IFN-gamma in mouse macrophages [AID224263, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | 50 percent inhibitory concentration of compound to inhibit nitric oxide production induced by IFN-gamma in mouse macrophages | | AID | 224263 | | BioAssay type | Literature | | Target | | | PubMed | 10794703 | | Data Table |  |
|
| 3 | [SID104234238] | Active | IC50 | 0.01 | Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamma) in mouse macrophages [AID224269, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibition of nitric oxide (NO) production induced by interferon-gamma (IFN-gamma) in mouse macrophages | | AID | 224269 | | BioAssay type | Literature | | Target | | | PubMed | 11063620 | | Data Table |  |
|
| 4 | [SID104234238] | Active | IC50 | 0.01 | Inhibitory activity against nitric oxide production induced by interferon-gamma (IFN-gamma) in mouse macrophages [AID224272, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Inhibitory activity against nitric oxide production induced by interferon-gamma (IFN-gamma) in mouse macrophages | | AID | 224272 | | BioAssay type | Literature | | Target | | | PubMed | 12383005 | | Data Table |  |
|
| 5 | [SID104234238] | Active | IC50 | 0.01 | Antiinflammatory activity in CD-1 mouse Macrophage assessed as inhibition of IFN-gamma induced NO production after 48 hrs by Griess reaction [AID589396, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Antiinflammatory activity in CD-1 mouse Macrophage assessed as inhibition of IFN-gamma induced NO production after 48 hrs by Griess reaction | | AID | 589396 | | BioAssay type | Literature | | Target | | | PubMed | 21361338 | | Data Table |  |
|
| 6 | [SID26751520] | Active | Potency | 0.0141 | qHTS assay for small molecule agonists of androgen receptor signaling [AID588515, Type: confirmatory] | AR protein [Homo sapiens] [gi:124375976] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS assay for small molecule agonists of androgen receptor signaling | | AID | 588515 | | BioAssay type | confirmatory | | Target | AR protein [Homo sapiens] [gi:124375976] | | PubMed | | | Data Table |  |
|
| 7 | [SID26751520] | Active | Potency | 0.0141 | qHTS assay for small molecule agonists of androgen receptor signaling [AID588515, Type: confirmatory] | AR protein [Homo sapiens] [gi:124375976] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS assay for small molecule agonists of androgen receptor signaling | | AID | 588515 | | BioAssay type | confirmatory | | Target | AR protein [Homo sapiens] [gi:124375976] | | PubMed | | | Data Table |  |
|
| 8 | [SID855803] | Active | Potency | 0.0141 | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway [AID895, Type: confirmatory] | NFKB1 protein [Homo sapiens] [gi:21620132] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway | | AID | 895 | | BioAssay type | confirmatory | | Target | NFKB1 protein [Homo sapiens] [gi:21620132] | | PubMed | | | Data Table |  |
|
| 9 | [SID855803] | Active | Potency | 0.0141 | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway [AID895, Type: confirmatory] | NFKB1 protein [Homo sapiens] [gi:21620132] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway | | AID | 895 | | BioAssay type | confirmatory | | Target | NFKB1 protein [Homo sapiens] [gi:21620132] | | PubMed | | | Data Table |  |
|
| 10 | [SID855803] | Active | Potency | 0.0141 | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway [AID895, Type: confirmatory] | NFKB1 protein [Homo sapiens] [gi:21620132] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway | | AID | 895 | | BioAssay type | confirmatory | | Target | NFKB1 protein [Homo sapiens] [gi:21620132] | | PubMed | | | Data Table |  |
|
| 11 | [SID855803] | Active | Potency | 0.0141 | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway [AID895, Type: confirmatory] | NFKB1 protein [Homo sapiens] [gi:21620132] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.0141 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway | | AID | 895 | | BioAssay type | confirmatory | | Target | NFKB1 protein [Homo sapiens] [gi:21620132] | | PubMed | | | Data Table |  |
|
| 12 | [SID104234238] | Active | IC50 | 0.015 | Compound was measured for its inhibitory activity on IFN-gamma-induced nitric oxide production in mouse macrophage [AID132492, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.015 [uM] | | BioAssay | Compound was measured for its inhibitory activity on IFN-gamma-induced nitric oxide production in mouse macrophage | | AID | 132492 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID104234238] | Active | IC50 | 0.026 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.026 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 14 | [SID104234238] | Active | IC50 | 0.026 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.026 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 15 | [SID104234238] | Active | IC50 | 0.026 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.026 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 16 | [SID104234238] | Active | IC50 | 0.026 | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) [AID625263, Type: other] | Glucocorticoid receptor [gi:121069] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.026 [uM] | | BioAssay | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | | AID | 625263 | | BioAssay type | other | | Target | Glucocorticoid receptor [gi:121069] | | PubMed | | | Data Table |  |
|
| 17 | [SID85148352] | Active | Potency | 0.0291 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85148352 | | CID | 5754 | | Outcome | Active | | Potency | 0.0291 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 18 | [SID85148352] | Active | Potency | 0.0291 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85148352 | | CID | 5754 | | Outcome | Active | | Potency | 0.0291 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 19 | [SID85148352] | Active | Potency | 0.0291 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85148352 | | CID | 5754 | | Outcome | Active | | Potency | 0.0291 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 20 | [SID85148352] | Active | Potency | 0.0291 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85148352 | | CID | 5754 | | Outcome | Active | | Potency | 0.0291 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 21 | [SID104234238] | Active | IC50 | 0.061 | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma induced NO production after 24 hrs by Griess reaction [AID589397, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 0.061 [uM] | | BioAssay | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of IFN-gamma induced NO production after 24 hrs by Griess reaction | | AID | 589397 | | BioAssay type | Literature | | Target | | | PubMed | 21361338 | | Data Table |  |
|
| 22 | [SID90341326] | Active | Potency | 0.0731 | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 90341326 | | CID | 5754 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 23 | [SID90341326] | Active | Potency | 0.0731 | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 90341326 | | CID | 5754 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 24 | [SID90341326] | Active | Potency | 0.0731 | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 90341326 | | CID | 5754 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 25 | [SID90341326] | Active | Potency | 0.0731 | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 90341326 | | CID | 5754 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID26751520] | Active | Potency | 0.0794 | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 27 | [SID26751520] | Active | Potency | 0.0794 | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 28 | [SID26751520] | Active | Potency | 0.0794 | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 29 | [SID26751520] | Active | Potency | 0.0794 | qHTS assay for small molecule agonists of glucocorticoid receptor signaling [AID588532, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26751520 | | CID | 5754 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS assay for small molecule agonists of glucocorticoid receptor signaling | | AID | 588532 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 30 | [SID56422453] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56422453 | | CID | 5754 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 31 | [SID56422453] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56422453 | | CID | 5754 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 32 | [SID56422453] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56422453 | | CID | 5754 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 33 | [SID56422453] | Active | Potency | 0.1636 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56422453 | | CID | 5754 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 34 | [SID855803] | Active | Potency | 0.1995 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 35 | [SID855803] | Active | Potency | 0.1995 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 36 | [SID855803] | Active | Potency | 0.1995 | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway [AID915, Type: confirmatory] | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway | | AID | 915 | | BioAssay type | confirmatory | | Target | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [Homo sapien [gi:32879895] | | PubMed | | | Data Table |  |
|
| 37 | [SID104234238] | Active | IC50 | 10 | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay [AID524791, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 10 [uM] | | BioAssay | Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay | | AID | 524791 | | BioAssay type | Literature | | Target | | | PubMed | 19734910 | | Data Table |  |
|
| 38 | [SID855803] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 855803 | | CID | 5754 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 39 | [SID104234238] | Active | IC50 | 40.64 | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by MTT assay [AID527190, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 40.64 [uM] | | BioAssay | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production by MTT assay | | AID | 527190 | | BioAssay type | Literature | | Target | | | PubMed | 20879743 | | Data Table |  |
|
| 40 | [SID104234238] | Active | IC50 | 40.64 | Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells after 24 hrs by Griess reaction based spectrophotmetry [AID617128, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | IC50 | 40.64 [uM] | | BioAssay | Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells after 24 hrs by Griess reaction based spectrophotmetry | | AID | 617128 | | BioAssay type | Literature | | Target | | | PubMed | 21807513 | | Data Table |  |
|
| 41 | [SID104234238] | Active | | | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL-10 production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control [AID595632, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL-10 production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control | | AID | 595632 | | BioAssay type | Literature | | Target | | | PubMed | 21384845 | | Data Table |  |
|
| 42 | [SID104234238] | Active | | | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL-6 production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control [AID595633, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL-6 production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control | | AID | 595633 | | BioAssay type | Literature | | Target | | | PubMed | 21384845 | | Data Table |  |
|
| 43 | [SID104234238] | Active | | | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL1-beta production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control [AID595634, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of IL1-beta production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control | | AID | 595634 | | BioAssay type | Literature | | Target | | | PubMed | 21384845 | | Data Table |  |
|
| 44 | [SID104234238] | Active | | | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of TNFalpha production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control [AID595635, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of TNFalpha production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by ELISA relative to control | | AID | 595635 | | BioAssay type | Literature | | Target | | | PubMed | 21384845 | | Data Table |  |
|
| 45 | [SID104234238] | Active | | | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by Griess reaction method relative to control [AID595637, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 0.5 to 50 ug/ml pretreated for 4 hrs followed by challenge with 1 ug/mL LPS for 48 hrs by Griess reaction method relative to control | | AID | 595637 | | BioAssay type | Literature | | Target | | | PubMed | 21384845 | | Data Table |  |
|
| 46 | [SID104234238] | Active | | | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay [AID521220, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay | | AID | 521220 | | BioAssay type | Literature | | Target | | | PubMed | 17417631 | | Data Table |  |
|
| 47 | [SID104234238] | Active | | | Antiinflammatory activity against croton oil-induced ear inflammation in BALB/c mouse at 200 ug/ear after 6 to 24 hrs [AID354573, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Antiinflammatory activity against croton oil-induced ear inflammation in BALB/c mouse at 200 ug/ear after 6 to 24 hrs | | AID | 354573 | | BioAssay type | Literature | | Target | | | PubMed | 8778246 | | Data Table |  |
|
| 48 | [SID104234238] | Active | | | Tested for inhibitory activity against T lymphocyte proliferation induced by Con A at 10e-7 M; showed potent suppressive effect [AID209947, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Tested for inhibitory activity against T lymphocyte proliferation induced by Con A at 10e-7 M; showed potent suppressive effect | | AID | 209947 | | BioAssay type | Literature | | Target | | | PubMed | 9871657 | | Data Table |  |
|
| 49 | [SID104234238] | Active | | | Tested for inhibitory activity against T lymphocyte proliferation induced by PHA at 10e-7 M; showed potent suppressive effect [AID209948, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Tested for inhibitory activity against T lymphocyte proliferation induced by PHA at 10e-7 M; showed potent suppressive effect | | AID | 209948 | | BioAssay type | Literature | | Target | | | PubMed | 9871657 | | Data Table |  |
|
| 50 | [SID104234238] | Active | | | Effect on modulation in uptake of [3H]progesterone in Escherichia coli AG102 with marR1 mutation [AID283561, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 104234238 | | CID | 5754 | | Outcome | Active | | BioAssay | Effect on modulation in uptake of [3H]progesterone in Escherichia coli AG102 with marR1 mutation | | AID | 283561 | | BioAssay type | Literature | | Target | | | PubMed | 17210767 | | Data Table |  |
|